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Abstract
Background: Hodgkin lymphoma is a hematologic malignancy usually confined to lymphatic structures and
commonly associated with constitutional symptoms. Bony involvement and musculoskeletal symptoms are
uncommon and typically seen in advanced disease. In this case, we report an unusual presentation of classical
Hodgkin lymphoma and highlight diagnostic challenges leading to the misdiagnosis and treatment as chronic
recurrent multifocal osteomyelitis.
Case presentation: A 38-year-old white man presented with lower extremity musculoskeletal pain. Imaging studies
revealed multifocal lytic and sclerotic osseous axial lesions. Multiple core needle bone marrow and excisional lymph
node biopsies were non-diagnostic. Having met the criteria, a tentative diagnosis of chronic recurrent multifocal
osteomyelitis was given. He was treated with non-steroidal anti-inflammatory medications with partial clinical
response but had persistent symptoms. A second medical opinion was pursued. An open bone marrow biopsy was
performed and yielded a diagnosis of classical Hodgkin lymphoma after 13 months of diagnostic uncertainty. A
chemotherapy regimen of doxorubicin, bleomycin, vinblastine, and dacarbazine was instituted with complete
symptomatic and radiologic response.
Conclusions: This case illustrates diagnostic difficulties of a musculoskeletal presentation of Hodgkin lymphoma,
challenges of non-diagnostic bone marrow and lymph node biopsies, and resultant diagnostic delays in delivering
a potentially curative therapy. Had the additional open bone marrow biopsy not been performed, the diagnosis
and treatment of Hodgkin lymphoma would have been missed.
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Background
Hodgkin lymphoma accounts for approximately 10% of
all known lymphomas and has an annual incidence rate
of approximately three cases per 100,000 people. Age
distribution is classically bimodal and, in industrial
nations, peaks at the second and after the sixth decade
of life. Treatment regimens developed over the years
have become highly effective, and commonly used
regimens in use today have remission rates approaching
80 to 90% after the initial course [1].
However, the etiology and mechanism of disease have yet
to be fully elucidated. It is thought that the development of
B cell-derived neoplastic cells arises from dysregulation of a
network of transcription factors at lymphoid germinal and
post-germinal centers. On histopathologic examination,
pathognomonic Reed–Sternberg cells and other neoplastic
variants are present in a mixed inflammatory infiltrate. This
infiltration into lymphoid tissue and surrounding organs
produces disease and symptoms [2].
In approximately 70% of patients, classical Hodgkin
lymphoma presents with painless lymphadenopathy pre-
dominantly in the cervical or supraclavicular lymphatic
chain distribution and, second most commonly, with an
asymptomatic mediastinal mass. In 20 to 40% of
patients, classic B-symptoms including fevers, night
sweats, or unintentional weight loss are present [3].
Musculoskeletal pain is an uncommon presentation and
can sometimes be misdiagnosed as osteomyelitis.
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Case presentation
A previously healthy 38-year-old white man presented
with left leg tightness and soreness. He had no signifi-
cant past medical history but did have an extensive
international travel history from his military service. His
family history was notable for a maternal history of blad-
der cancer; a social history disclosed a remote 13-year
chewing tobacco history with current cigar smoking
accruing to approximately 1.3 cigar-years.
Over a span of approximately 6 months, his left leg
tightness and soreness progressed to include his left low
back along with sensory changes along his left lateral
foot and heel that rendered him with intermittent
physical limitation. A review of his symptoms was other-
wise unrevealing with no constitutional symptoms. A
physical examination was notable for “shotty” supraclavi-
cular lymphadenopathy.
An initial evaluation at an outside institution was ultim-
ately inconclusive. Serial magnetic resonance imaging
(MRI) and computed tomography (CT) of his chest,
abdomen, and pelvis showed progressive and aggressive-
appearing mixed sclerotic-lytic lesions in his iliac and
sacral regions. One sacral lesion extended into the left S1
neural foramen. There was associated widespread lymph-
adenopathy involving the supraclavicular, mediastinal, ab-
dominal, and pelvic regions. Multiple tiny pulmonary
nodules up to 10 mm were also present. All imaging ap-
peared consistent with multifocal osteomyelitis although a
malignant or infectious process could not be ruled out.
The results of cursory laboratory tests were unremark-
able and notable for only a mildly elevated sedimenta-
tion rate of 39 mm/hour. Rheumatic serologies and
hematologic workup were unrevealing. Extensive
infectious studies yielded no identifiable microorganism.
Multiple biopsies were sought. A left axillary lymph
node excisional biopsy disclosed reactive lymphadenop-
athy with scattered pigment-laden macrophages and
extensive fatty replacement. Right and left iliac bone
marrow biopsies showed marrow fibrosis with focally
prominent chronic inflammatory infiltrates. There was
no evidence of mycobacterial or fungal organisms. Bone
marrow flow cytometry showed no monoclonal B cell
population. All biopsies were without evidence of
lymphoma or any other neoplastic processes.
A provisional diagnosis of non-bacterial chronic recur-
rent multifocal osteomyelitis (CRMO) was given. He was
treated with opioids, and then transitioned to non-steroidal
anti-inflammatory drugs (NSAIDs) and a course of physical
therapy. His symptoms improved on this treatment regi-
men. He received no glucocorticoid during this time.
By the time of presentation to our institution, his clin-
ical course had significantly improved over several
months but had not resolved. A repeat positron emission
tomography (PET)-CT scan showed hypermetabolic foci
throughout his torso involving lymph nodes, bones, and
lungs as pictured in Fig. 1. The largest lymph nodes
measured up to 1.6×2.0 cm at the left supraclavicular
fossa, 2.0 cm at the celiac chain, and 3.1×1.8 cm at the
anterior aortocaval chain. Availability of prior study mea-
surements were lacking for comparison. Lytic-sclerotic
lesions were re-demonstrated and involved his sacrum, left
posterior iliac, right supra-acetabular iliac wing, and left
anterior tenth rib. Multiple sub-centimeter lung nodules
were re-demonstrated in the upper lobes of his left and
right lungs. No splenomegaly was present.
An open bone biopsy of his left iliac crest was then
performed and finally revealed a diagnosis of classical
Hodgkin lymphoma after 13 months of diagnostic un-
certainty. Histologic study demonstrated fibrosis and an
inflammatory infiltrate. Newly noted were collections of
mummified and lacunar cells with abundant basophilic
cytoplasm. Also observed were large multilobed nuclei
consistent with Reed–Sternberg and Hodgkin cells as
seen in Fig. 2.
He was started on a doxorubicin, bleomycin,
vinblastine, and dacarbazine (ABVD) chemotherapy regi-
men without radiation therapy. Significant clinical and
Fig. 1 Nuclear positron emission tomography-computed tomography
showing multiple foci involving lymph nodes at the paratracheal, left
supraclavicular, para-aortic, and right inguinal regions. There was also
hypermetabolic activity involving bilateral lung parenchyma and left
tenth rib
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radiologic responses were seen after two cycles. A whole
body PET-CT revealed significant reductions in meta-
bolic activity with resolution of his presenting symp-
toms. After completion of six cycles, the PET-CT was
consistent with complete remission.
Discussion
Here, we report a rare case of classical Hodgkin lymph-
oma mimicking a presentation of CRMO.
Our patient presented with painless supraclavicular
lymphadenopathy and musculoskeletal symptoms which
appeared responsive to NSAID therapy. Tobacco use ap-
peared to be the only known exposure risk factor [4].
His laboratory workup was consistent with CRMO and
was notable for elevated inflammatory markers, mixed
sclerotic-lytic bony lesions on imaging, and multiple
core-needle bone marrow and excisional lymph node bi-
opsies showing only a mixed inflammatory infiltrate
without evidence of malignancy or infection. At that
juncture, he had met and exceeded the diagnostic
threshold for CRMO proposed by Jansson et al. with
three major and three minor criteria met as outlined in
Table 1 [5]. Further, the significant and durable response
to NSAIDs provided a false positive therapeutic trial as
NSAIDs are first-line treatment for CRMO [6, 7]. The
pain relief observed may have been multifactorial to
decreased bony swelling atop the usual inhibition of
cyclooxygenase-derived pain mediators [8, 9].
Since CRMO is a diagnosis of exclusion, a potential
diagnostic pitfall exists in relying on a non-diagnostic
bone marrow biopsy to rule out a neoplastic cause. This
challenge is highlighted with classical Hodgkin lymph-
oma as diagnostic Reed–Sternberg and Hodgkin cells
can be rare and missed due to sampling error.
A survey of the literature reveals sporadic case reports
of Hodgkin lymphoma presenting with musculoskeletal
pain and an initial misdiagnosis as an osteomyelitis syn-
drome. Of interest, the vast majority of these cases were
associated with primary osseous Hodgkin lymphoma.
Ha-ou-nou et al. reported an uncannily similar case of
a 35-year-old man presenting with sacral pain and was
found to have numerous sacral and iliac osteolytic le-
sions without B-symptoms or lymphadenopathy [10]. A
bone marrow biopsy was non-diagnostic but empiric
chemotherapy for Hodgkin lymphoma resulted in reso-
lution of symptoms and lytic lesions [10]. Furthermore,
a case series by Ostrowski et al. examined 25 patients
with biopsy-proven, osseous Hodgkin’s involvement.
Nearly all presentations involved bony pain and many
had an initial misdiagnosis of osteomyelitis [11]. A hand-
ful of other cases with similar presentation and misdiag-
nosis have been described in the literature [12–15].
It is unclear if our patient had primary osseous
classical Hodgkin lymphoma due to an inability to prove
the osseous lesions as the primary originating site in the
setting of widespread lymphadenopathy already present
on his initial medical evaluation. The other possibility
would be the more common lymph node-originating
Hodgkin lymphoma with progression to bone marrow
involvement.
Conclusions
Ultimately, the presenting complaint of musculoskeletal
symptoms in our case affirms the heterogeneity of
possible Hodgkin lymphoma presentations and enhances
Fig. 2 As seen in Panel a, low-powered field of the gross bone
specimen showing lymphoid tissue nodule (arrow) surrounded by
faint bands of collagen. Classic multinucleated and bi-lobed
Reed–Sternberg cells with surrounding lacunae (Panel b, solid
arrows) are shown in a background of a heterogeneous
inflammatory infiltrate. A mummified Reed–Sternberg cell is shown
(Panel b, open arrow). Further immunohistochemical staining showed
positive cluster of differentiation 15 (Panel c) and membrane-distributed
cluster of differentiation 30 (Panel d) Reed–Sternberg cells characteristic
of classical Hodgkin lymphoma
Table 1 Classification of non-bacterial osteitis




2. Multifocal bone lesions
3. Pustulosis palmoplantaris
or psoriasis
4. Sterile bone biopsy with signs
of inflammation and/or fibrosis
and sclerosis
A. Normal blood count and good
general state of health
B. CRP and ESR mildly-to-moderately
elevated
C. Observation time longer than
6 months
D. Hyperostosis
E. Associated with other autoimmune
diseases apart from pustulosis
palmoplantaris or psoriasis
F. Grade I or II relatives with autoimmune
or auto-inflammatory disease, or
with NBO
CRP C-reactive protein, ESR erythrocyte sedimentation rate, NBO non-bacterial
osteitis. (2 – As proposed by Jansson et al. [5], Classification of Non-Bacterial
Osteitis: Retrospective study of clinical, immunological and genetic aspects in
89 patients. Rheumatology (2007), 46 (1): 154–160. Permission granted from
Oxford University Press.)
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our appreciation for the diagnostic quandary this can en-
tail. The misdiagnosis early in our patient’s clinical
course highlights the pitfall of using a non-diagnostic
bone marrow and lymph node biopsies to exclude Hodg-
kin lymphoma. Where tissue biopsy is non-diagnostic,
there should be thoughtful consideration for additional
tissue biopsies; and, in our case, an open bone biopsy
was the critical factor in revealing the diagnosis. Other-
wise, a misdiagnosis of CRMO could have easily resulted
and delayed therapy in a highly treatable malignancy.
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